EPHA2 agonistic monoclonal antibodies and methods of use thereof

Details for Australian Patent Application No. 2012202569 (hide)

Owner Medlmmune, LLC Purdue Research Foundation

Inventors Stewart, Jane C.; Kinch, Michael S.; Carles-Kinch, Kelly

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012202569

Parent 2004293034

Filing date 2 May 2012

Wipo publication date 24 May 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

17 May 2012 Complete Application Filed

24 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202569

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202570-Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

2012202568-Oxidizing composition for salt water